(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 10.46% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.46%.
Sight Sciences's revenue in 2026 is $79,553,000.On average, 9 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,774,581,230, with the lowest SGHT revenue forecast at $4,511,019,471, and the highest SGHT revenue forecast at $4,982,372,799. On average, 9 Wall Street analysts forecast SGHT's revenue for 2027 to be $5,309,376,550, with the lowest SGHT revenue forecast at $4,942,925,591, and the highest SGHT revenue forecast at $5,708,147,015.
In 2028, SGHT is forecast to generate $5,754,395,466 in revenue, with the lowest revenue forecast at $5,305,513,444 and the highest revenue forecast at $6,233,202,956.